��ѻ��ý

2006 Lucas GM, Griswold M, Gebo KA, Keruly J, Chaisson RE, and Moore RD. “Illicit Drug Use and HIV-1 Disease Progression: A Longitudinal Study in the Era of Highly Active Antiretroviral Therapy”, Am J Epidemiol 2006;163:412-420.

Barry PM, Zetola N, Keruly JC, Moore RD, Gebo KA, Lucas GM. Invasive pneumococcal disease in a cohort of HIV-infected adults: incidence and risk factors, 1990 – 2003. AIDS 2006 Feb 14;20(3):437-44.

Sheth AN, Moore RD, and Gebo KA*. “Provision of General and HIV-Specific Health Maintenance in an Urban HIV Clinic”, AIDS Care and STDs 2006 May;20(5):318-25.

2005 Gebo KA, Fleishman JA, Conviser R, et al. “Racial and Gender Disparities in Receipt of HAART Persist in a Multi-State Sample of HIV Patients in 2001”, J Acquir Immune Defic Syndr 2005;38:96-103

Moore RD, Keruly JC, Gebo KA, Lucas GM. “An improvement in virologic response to HAART in clinical practice from 1996-2002”, J Acquir Immune Defic Syndr. 2005 Jun 1;39(2):195-8.